Advancing Precision Medicine in Cancer Care with LifeOmic Oncology: Improving Outcomes and Efficiency
Precision medicine is an approach to healthcare that takes into account individual variations in genes, environment, and lifestyle when diagnosing and treating patients. The core principles of precision medicine involve tailoring medical decisions and treatments to the specific characteristics of each patient, with the aim of improving outcomes and minimizing side effects. This approach recognizes that individuals may respond differently to the same treatment due to genetic variations and other factors, and seeks to optimize care based on this understanding.
Precision medicine in cancer care offers clinical and economic benefits
Precision medicine offers substantial benefits in cancer care, both clinically and economically. By analyzing an individual’s genomic profile and biomarkers, clinicians can select therapies that directly target the underlying mechanisms of the disease, improving treatment response rates and patient outcomes. Early detection facilitated by precision medicine allows for timely interventions and higher chances of successful treatment. It also aids in monitoring disease progression, adjusting treatment plans, and identifying potential drug resistance. From an economic standpoint, precision medicine reduces healthcare costs by avoiding ineffective treatments, optimizing therapy selection, and minimizing adverse effects. By tailoring therapies to the molecular characteristics of a patient’s tumor, precision medicine improves treatment efficacy, reducing the need for costly and futile, potentially harmful interventions. It also maximizes healthcare resource utilization, preventing unnecessary expenditures and enhancing the overall effectiveness of cancer treatment strategies.
Real-world implementation of precision medicine programs is challenging
Despite the substantial benefits of precision medicine in cancer care, the widespread implementation of precision medicine programs encounters various challenges. These obstacles include limited data accessibility, high costs, and time limitations, particularly in resource-constrained settings. Acquiring and integrating comprehensive datasets including genomic information, clinical records, and clinical trial and treatment options is complex and time-consuming. Oncologists and pathologists often spend extensive hours reviewing data from various unconnected platforms to prepare for cases receiving precision medicine treatments. Integrating diverse data sources and navigating through complex information is time-consuming, limiting the efficiency and scalability of precision medicine approaches.
LifeOmic Oncology breaks down data silos and is revolutionizing efficiency and patient throughput in oncology
LifeOmic Oncology is transforming efficiency and patient throughput in oncology care by streamlining processes and leveraging advanced technology, including artificial intelligence. LifeOmic Oncology is a secure, cloud-based platform that consolidates data from various siloed systems, providing clinicians with comprehensive visualization and filtering tools. LifeOmic Oncology also enables clinicians to explore potential therapy and trial matches quickly by delving into a patient’s genetic data using independent databases such as the Jackson Labs Cancer Knowledgebase, NIH ClinVar, and Clinicaltrials.gov. These features empower clinicians to gain a complete overview of their patients and create personalized treatment plans within a single, integrated platform available from within their native EHR system.
At Indiana University Health, LifeOmic Oncology significantly reduced the time spent interpreting each patient’s genetic data by more than 60% for the precision genomics team, translating into hours saved each week. It also facilitated the seamless pre-filling of clinical trials by swiftly identifying eligible patients. These time and cost savings translate into more dedicated care for patients and increased patient throughput.
By leveraging LifeOmic Oncology, oncologists can optimize their workflow, reduce administrative tasks, and improve patient care. This increased efficiency and reduced administrative burden ultimately leads to a decreased risk of burnout and allows oncologists to dedicate more time to higher-level activities, such as establishing stronger patient relationships, research, and education.
LifeOmic recently introduced an interactive, web-based ROI (return-on-investment) calculator that estimates the annual hours saved and the economic value of time savings that can be achieved using LifeOmic Oncology. The ROI calculations are based on multiple variables, including annual patient volume and minutes saved per patient. At a hospital treating 3,000 cancer patients annually, the calculator estimates an annual savings of nearly 43,000 hours and 13 million dollars. To estimate your institution’s potential ROI with LifeOmic Oncology, use the LifeOmic ROI calculator.
